Table 1.

Molecular Genetic Testing Used in Autosomal Recessive Spondylocostal Dysostosis

Gene 1, 2Proportion of AR SCDO Attributed to Pathogenic Variants in Gene 3Proportion of Pathogenic Variants 4 Detectable by Method
Sequence analysis 5Gene-targeted deletion/duplication analysis 6
DLL3 ~60% 795%2 individuals 8
HES7 ~5% 9100%None reported 10
LFNG ~5%100%None reported 10
MESP2 ~5% 11100%None reported 10
RIPPLY2 ~5%100%None reported 10
TBX6 ~20% 12100%See footnote 13.
UnknownSee footnote 14.

AR = autosomal recessive; SCDO = spondylocostal dysostosis

1.

Genes are listed in alphabetic order.

2.
3.

The percentages in column two are estimates based on published reports [Authors, personal communication].

4.

See Molecular Genetics for information on variants detected in these genes.

5.

Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click here.

6.

Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods used may include a range of techniques such as quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.

7.
8.

One individual with a deletion of exons 2-4 (detected by an in-house-designed MLPA kit) and one individual with a whole-gene deletion (detected by array CGH and confirmed by in-house-designed MLPA) [Authors, personal communication]

9.

Three reported families and an additional four unreported individuals [P Turnpenny, personal communication]

10.

No deletions or duplications involving HES7, LFNG, MESP2, or RIPPLY2 have been identified in individuals with autosomal recessive SCDO [Authors, personal communication].

11.

Three known families with MESP2-related SCDO [Whittock et al 2004b; Authors, unpublished data]

12.

Six families with TBX6-related SCDO have been reported [Lefebvre et al 2017; P Turnpenny, personal communication].

13.

Large TBX6 deletions/duplications have not been reported in individuals with autosomal recessive SCDO. Heterozygous TBX6 deletions, sometimes in trans with a hypomorphic allele, have been reported in individuals with congenital scoliosis and müllerian aplasia or renal malformations (see Genetically Related Disorders) [Sandbacka et al 2013, Wu et al 2015, Li et al 2022].

14.

One individual with an SCDO-like phenotype including multiple regional segmentation defects of the vertebrae and multiple intervertebral fusions of laminae, in addition to dysmorphic features and cleft palate, was homozygous for a DMRT2 start-loss variant [Bouman et al 2018]. With severe left-sided rib cage deficiency, the infant died at age nine days; to date, it is not known whether DMRT2-related SCDO is a distinct entity.

From: Spondylocostal Dysostosis, Autosomal Recessive

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.